Showing 2701-2710 of 5128 results for "".
How to Use Email Effectively to Build Client Loyalty
https://practicaldermatology.com/topics/practice-management/email-loyalty/18218/Using email effectively can help you encourage client loyalty as well as client satisfaction. This Ekwa Marketing video explains how you can do this to optimize client experience and motivate clients to return.Google Webmaster Tools
https://practicaldermatology.com/topics/practice-management/google-webmaster-tools/18285/Google encourages online marketing teams and website owners to use organic, genuine methods to achieve more search engine visibility for their websites. This Ekwa Marketing video explains how Webmaster Tools by Google makes this easier, by helping dermatology website marketers to meet and exceed theHad Your Fill?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/had-your-fill/18531/If the US filler market seems robust, you should see what's available outside the US, says Hassan Galadari, MD. He provides a global perspective on fillers with a focus on up-and-coming products, the importance of understanding anatomy, and advances in recognizing and treating complications.Mentors in Dermatology
https://practicaldermatology.com/topics/practice-management/mentors-in-dermatology/18719/Neal Bhatia, MD sat down with one of his mentees, Al Damavandy, MD, to discuss what makes a great mentee-mentor relationship and how both parties can benefit. Dr. Damavandy, now a practicing Mohs Surgeon and Dermatologist, shared tips for how to find the right mentor and what he learned from his menVegas Cosmetic Surgery 2016 Update
https://practicaldermatology.com/topics/practice-management/vegas-cosmetic-surgery-2016-update/18764/Highlights from the Vegas Cosmetic Surgery 2016 meeting at the Bellagio hotel. Get insights from speakers: Timothy Miller, MD, Jason Bloom, MD, Jeffrey Spiegel, MD, David Evans, Mara Shorr, BS, CAC II-VII, Donn Chatham, MD, Wendy Lee, MD, Jay Shorr, BA, MBM-C, CAC I-VIII. Topics include neurotoxins,To Be Shorr: Your receptionist is director of first impressions
https://practicaldermatology.com/topics/practice-management/to-be-shorr-your-receptionist-is-director-of-first-impressions/18603/Th best physicians and surgeons can see their practice fall apart if they lack good staff. The receptionist is often the first contact a patient has with your practice. Think of this individual as your director of first impressions, says Mara Shorr, BS, CAC II-V.The Complex World of Biosimilars
https://practicaldermatology.com/topics/psoriasis/the-complex-world-of-biosimilars/18633/Jashin Wu, MD, discusses potential concerns with biosimilars, including the chance of inducing variable immunogenic responses compared with reference agents. Although there are currently no biosimilars approved for use in psoriasis in the United States, these agents are fast approaching market availThe Evolving Paradigm in Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/the-evolving-paradigm-in-treatment-of-psoriasis/18640/Bruce Strober, MD, reviews the latest science in the management of psoriasis. Treatment strategies on the horizon may offer significantly improved efficacy with attractive dosing schedules, adding to the ability to help patients manage difficult skin and systemic implications of psoriasis, he said.Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of ImlygicEpiduo Forte Approved; Facial Aesthetics By Age
https://practicaldermatology.com/topics/practice-management/dermwiretv-epiduo-forte-approved-facial-aesthetics-by-age/18870/Galderma's non-antibiotic Epiduo Forte (Adapalene 0.3% and benzoyl peroxide 2.5%) approved for topical management of acne vulgaris. Trends reveal differences in women's facial cosmetic surgery by age. AMA and CMS offer ICD-10 help. Plus: An Update on NewDerm LIVE.